Accepted at 6:21 p.m. Dec, 23, 2023 by Ahmed7
Author: NiceJewishBoy
Related Note: 1472000217588
Rationale for change

m

Extra Extra
Text
Class I{{c4::C}} antiarrhythmics may have {{c3::proarrhythmic}} effects and are thus contraindicated in patients with {{c1::structural}} heart disease or {{c2::ischemic}} heart disease
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy Extra
Empty field
Picmonic
Empty field
Physeo

OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#OME::PreClinical::Cardiac::Cardiac_5::Electricity::Arrhythmias #AK_Step2_v12::#B&B::02_Cardio::01_Arrhythmias::03_Atrial_Fibrillation_and_Flutter::Extra !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::04_Antiarrhythmics::01_Class_I_A-C #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::04_Tachycardia::04_Narrow_Complex_Tachycardia:_AFib_&_AFlutter_Management #AK_Step1_v12::#Bootcamp::Cardiology::13_Antiarrhythmics::02_Class_I_Antiarrhythmics #AK_Step1_v12::#B&B::05_Cardio::04_Arrhythmias::06_Antiarrhythmic_Drugs_I #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::17_Class_IA,_IB,_and_IC_Antiarrhythmics #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::05_Class_IC_Antiarrhythmics #AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::09_Class_IC_Antiarrhythmics #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::12_Antiarrhythmics-sodium_channel_blockers_(class_I)::01_Class_IA::*16_Antiarrythmics::Class_1_Sodium_Channel_Blockers